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1. ABBREVIATIONS
[ion or substrate] – concentration of ion or substrate 
[ion]i – intracellular ion concentration 
[ion]o – extracellular ion concentration 
[ion]ss – ion concentration in submembrane space 
ADP – adenosine diphosphate 
AM - acetoxymethyl 
ATP – adenosine triphosphate 
CaMKII - Ca2+-calmodulin dependent protein kinase II 
CHF – congestive heart failure 
CICR – Ca2+ induced Ca2+ release 
cSEVC - continuous single electrode voltage clamp 
DAD – delayed afterdepolarizations 
DHO – dihydro-ouabain 
dSEVC - discontinuous single electrode voltage clamp 
ICa,L – L-type calcium current 
IK1 – inward rectifier potassium current 
IKr – delayed rectifier potassium current 
INa – sodium current 
INCX – Na+/Ca2+-exchanger current 
INKA – Na+/K+-ATPase current 
Ito - transient outward potassium current 
K0.5 – half-maximal activation constant (affinity) 
LVEDP - left ventricular end diastolic pressure 
NCX – Na+/Ca2+-exchanger 
NKA – Na+/K+-ATPase
Pi – free phosphate 
PKA – protein kinase A 
PKC – protein kinase C 
RyR – ryanodine receptor 
SBFI - sodium-binding benzofurzan isophthalate 
SERCA – sarcoendoplasmic reticulum calcium ATPase 
SR – sarcoplasmic reticulum 
Vmax – maximal pump rate 
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3. INTRODUCTION
3.1.Cardiac function 
3.1.1. The normal heart 
The heart is responsible for pumping blood in the circulatory system allowing 
transport of nutrients, water, oxygen, carbon dioxide, etc. in the body. The heart must 
constantly regulate its contractile force to meet the variable demands of the body. In 
skeletal muscles, contractile force is adjusted by recruiting more or fewer muscle 
fibres. However, in the heart this is not possible since all the cardiomyocytes are 
electrically coupled. Therefore, contractility must be adjusted at the level of the 
individual cardiomyocyte. 
 Developed force in single cardiomyocytes is regulated by a multitude of 
mechanisms. The concerted action of these mechanisms constitutes what is known 
as the excitation-contraction-relaxation coupling and converts the electrical stimulus 
of the cardiomyocyte to mechanical response. A key process in the excitation-
contraction-relaxation coupling is transport of ions across the sarcolemma through 
ion transporting proteins and within the cardiomyocyte. In recent years, several  
12 
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Figure 1. Schematic representation of key proteins in the excitation-contraction-relaxation 
coupling. These proteins cooperate to transport ions during the cardiac cycle. LTCC, L-type 
Ca2+ channel; NCX, Na+/Ca2+-exchanger; NKA, Na+/K+-ATPase; RyR, Ryanodine receptor, 
SERCA, sarcoplasmic reticulum Ca2+ ATPase; SR, sarcoplasmic reticulum. 
observations have lead researchers to propose that diffusion of ions in 
cardiomyocytes is slower than in water. It follows that ion concentrations can be 
different in various spaces in the cardiomyocyte. For example, the concentration of 
Na+ would be much higher at the mouth of an open Na+ channel than in the bulk 
cytosol 149. With diffusion of ions restricted to discrete spaces, excitation-contraction-
relaxation coupling seems to occur without the need of individual ions to travel very 
far. This is reflected in the morphology of cardiomyocytes which have invaginations 
of cell membrane called t-tubules. T-tubules connect the excitable membrane to the 
13 
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sarcoplasmic reticulum (SR), which is an intracellular Ca2+ store. An influx of Ca2+
over the t-tubule membrane can thus locally trigger a larger release of Ca2+ from the 
SR which will trigger the contraction. Figure 1 shows an overview of key proteins 
participating in the excitation-contraction-relaxation coupling and their respective ion 
fluxes. Recent advances in excitation-contraction-relaxation coupling research have 
demonstrated that Na+ plays an important role as a regulator for Ca2+ handling. 
However, the mechanisms behind this regulation are still unclear. The excitation-
contraction-relaxation coupling will be presented in more detail below. 
3.1.2. The failing heart 
Heart failure is a common disease, with more than 550 000 new cases per year in 
the US alone. It is primarily a condition in the elderly with ~80% of patients being 
above the age of 65. Thus, aging of the population contributes to increased 
prevalence and an increasing number of hospitalizations. Despite advances in the 
treatment of the disease, the number of deaths from heart failure has increased 
steadily during recent years. One probable cause for this, is that better treatment and 
early interventions rescues more patients from dying from myocardial infarctions 
earlier in life 62. However, these patients later develop heart failure. 
 Heart failure may have various etiologies including hypertension, myocardial 
infarction, valvular heart disease and cardiomyopathies, and has been defined as “a 
pathophysiological state in which the heart is unable to pump blood at a rate 
commensurate with the requirements of the metabolizing tissues or can do so only 
from an elevated filling pressure” 26. It is often described as a systolic or diastolic
heart failure. During systolic heart failure, the ability of the heart to eject blood during 
systole is impaired. In contrast, systolic function can be preserved during diastolic 
heart failure in which diastolic filling of the ventricle is impaired. Ventricular stiffening 
14 
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is an important contributor to diastolic heart failure which is particularly prevalent in 
older patients, women and in patients with hypertension 27. Heart failure caused by 
chronic ischemic heart disease is the most common form and is often a combined 
systolic and diastolic heart failure 27.
In the acutely failing heart following a large infarct, function of surviving 
myocardium might be normal, or even enhanced. However, the myocardium is 
gradually remodelled after an index event. Remodelling comprises both 
morphological and functional aspects, and generally results in reduced cardiac 
function. First, structural remodelling can develop at the macroscopic level with left 
ventricular dilatation and/or myocardial fibrosis and reorganization. Second, structural 
remodelling of the cardiomyocytes develops during chronic congestive heart failure 
(CHF), as discussed in the present thesis. Third, myocardial function is altered, 
although both enhanced 88 and reduced 122;147 function has been observed. Also, 
control of intracellular Na+ concentration is reduced in the remodelled myocardium 
(discussed later in this thesis). Remodelling of the left ventricle results in reduced 
cardiac performance in the chronic failing heart.  
The contractile defect observed in myocardial heart failure in rats can be 
quantified in vivo by reduced fractional shortening and reduced shortening 
velocity 123;124. This defect is also commonly observed in isolated cardiomyocytes 121,
but not in all experiments 88. Also delayed relaxation is a common finding in failing 
cardiomyocytes 124;147. These defects can in part be explained by alterations in 
excitation-contraction-relaxation coupling 20.
15 
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3.2.Excitation-contraction-relaxation coupling 
3.2.1. The action potential 
Excitation-contraction-relaxation coupling is initiated by an action potential. The 
action potential is a transient change in the membrane potential, resulting from an 
intricate interplay between several ion transporting proteins. It propagates in the 
cardiomyocyte by a combination of facilitated diffusion of Na+ through open voltage-
gated Na+ channels and passively spreading membrane depolarization. When Na+
channels open in a region of cell membrane, positive charges (Na+) enters the cell. 
By electrostatic repulsion, adjacent ions are “pushed” through the cytoplasm, 
resulting in a wave of positivity to downstream regions. This depolarizes the 
neighbouring membrane to the threshold value for opening of Na+ channels, and the 
process repeats itself 12. The propagation from cell to cell is permitted by gap 
junctions in the intercalated discs of the cardiomyocytes. It is important to point out 
that by this propagation mechanism, individual ions do not need to be moved very 
far.
 The action potential can be described as four successive phases: 
"#$%
#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#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#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Figure 2. The phases of the 
action potential.
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Phase 0 is a depolarizing phase where Na+ flows into the cell through Na+
channels. During this phase, the membrane potential changes from its resting value 
of ~-80 mV and reaches typically +35-50 mV 12. The Na+ channels inactivates within 
~1 ms, so despite a very large peak Na+ current (INa >1 nA/pA 12), the amount that 
enters can only raise bulk intracellular Na+ concentration ([Na+]i) by 6-15 μM 15. Yet, 
because of slow diffusion of Na+ in the cytosol, local [Na+] in the subsarcolemmal 
space ([Na+]ss) during INa may be 60 times higher than bulk [Na+]i 149.
Phase 1 is an early repolarizing phase mainly carried by a transient outward 
K+ current (Ito). Differences in the repolarizing phase are seen between species, but 
also between cardiomyocytes from different regions of the ventricle, and have been 
explained by varying amounts of Ito 141. Because the early repolarization phase is so 
great in rat and mouse ventricular cardiomyocytes, they have almost no plateau 
phase (see below). During this phase, the action potential is more positive than the 
reversal potential for a Na+/Ca2+-exchanger which then operates in the its reverse 
mode, bringing Ca2+ into the cell 69.
Phase 2 is a plateau phase where the membrane potential changes slowly. 
During this phase, inward currents mainly through L-type Ca2+ channels are almost in 
balance with outward currents carried by delayed rectifier K+ channels (IKr). The Ca2+
coming in over the sarcolemma will trigger a larger release of Ca2+ from the SR by 
binding to SR Ca2+ release channels, or ryanodine receptors (RyR), by a process 
called Ca2+ induced Ca2+ release (CICR) 46. This Ca2+ binds to troponin C in the 
myofilaments, causing the contraction of the cardiomyocyte. 
Phase 3 is a repolarizing phase. This phase is mainly driven by K+ channels. 
As repolarization proceeds, outward current through inward rectifier K+ channels (IK1)
and delayed rectifier K+ channels (IKr) increases, and brings the potential towards the 
17 
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resting potential. During this phase, intracellular Ca2+ concentration ([Ca2+]i) is still 
relatively high. Together with the low membrane potential, this favours forward mode 
Na+/Ca2+-exchange (Ca2+ extrusion). 
A fifth phase (phase 4) is also sometimes described. In ventricular 
cardiomyocytes, this phase consists of the resting period between action potentials, 
where the membrane potential is held at ~-80 mV. This phase is maintained mainly 
by IK1 until a new action potential is triggered. In cells with spontaneous pacemaker 
activity, there is a gradual depolarization during this phase. These cells have little or 
no IK1 12. When the membrane potential reaches threshold values for INa, a new 
action potential is elicited. 
 During heart failure, the action potential is prolonged. This has been attributed 
to a reduction in Ito 137. Since Ito profoundly influences phase 1 and the level of the 
plateau, it also affects all the other currents that are active later in the action 
potential. One protein of which the function is highly dependent on the membrane 
potential is the Na+/Ca2+-exchanger. Prolongation of the plateau phase of the action 
potential could prolong the period for Ca2+ influx 44, or at least reduce the Ca2+ efflux 
via Na+/Ca2+-exchangers. This would contribute to the delayed relaxation seen in 
heart failure. 
3.2.2. Triggers of Ca2+ release 
Already in 1883, Sydney Ringer discovered that cardiac muscle contraction is 
dependent on extracellular Ca2+ 101. Indeed, Ca2+ must enter the cardiomyocyte to 
trigger a larger release from the SR. This occurs by two mechanisms: through L-type 
Ca2+ channels and to a lesser extent by reverse mode Na+/Ca2+-exchange. 
The L-type Ca2+ channel is a voltage dependent channel which passes Ca2+
current (ICa,L) when it is open. The ICa,L constitutes the main trigger mechanism for SR 
18 
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Ca2+ release and is dependent on membrane potential in a bell-shaped manner. 
Maximum ICa,L is reached at ~0 mV, with little or no current at potentials negative to 
-40 mV and positive to +40 mV. During Phase 1 of the action potential, L-type Ca2+
channels open rapidly and ICa,L reaches a peak within 2-7 ms 12. The ICa,L is sustained 
through phase 1 and 2, but then declines. The inactivation of the L-type Ca2+ channel 
is dependent on time, membrane potential and [Ca2+]i. Thus, Ca2+ constitutes a 
negative feedback signal to close the L-type Ca2+ channel. The amount of Ca2+ that 
enters the cardiomyocyte is dependent on both activation and inactivation of ICa,L.
Since the action potential is shorter in the rat than in other species, the influx of Ca2+
through ICa,L during each cycle is also smaller in the rat; 14 μmol/l cytosol 
(vs. 21 μmol/l cytosol in rabbits) 12. However, important Ca2+ buffers are present in 
the cytosol, so an entry of 14 μmol/l cytosol would result in a much smaller rise in 
free [Ca2+]i (ratio of 90:1 9;12). On the other side, it now seems clear that local 
subsarcolemmal Ca2+ ([Ca2+]ss) in the dyadic cleft can be raised from 0.1 μM to more 
than 10 μM by ICa,L 18. For this to occur, diffusion of Ca2+ must be restricted to a 
submembrane space. The increase in Ca2+ triggers a larger release of Ca2+ from the 
SR (see below). 
In most models of heart failure, peak ICa,L density is found to be 
unaltered 122;124. However, the ability of ICa,L to trigger contractions is still a matter of 
debate 54;122. At the single channel level, it has been reported that the opening 
probability and availability of L-type Ca2+ channels are increased in human heart 
failure 107. However, counterbalanced by a reduced number of L-type Ca2+ channel 
protein copies in heart failure 59, this fits with unaltered peak ICa,L density, but could 
result in reduced trigger efficiency. In line with this, a defective interaction between 
the L-type Ca2+ channel and RyR has been proposed in heart failure 53. It has also 
19 
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been proposed that remodelling of t-tubules leads to orphaned RyR 128. Thus, it 
appears to be a marked decrease in the ability of the L-type Ca2+ channel to activate 
RyRs in heart failure 32. In other words, the gain of CICR may be reduced if the L-
type Ca2+ channel protein expression or cardiomyocyte micro-architecture is altered. 
Reverse mode Na+/Ca2+-exchange, bringing Ca2+ into the cardiomyocyte, 
was proposed as a trigger for SR Ca2+ release for the first time in 1990 69. Since then, 
several studies have confirmed this role of the Na+/Ca2+-exchanger 74;102. The major 
part of Na+/Ca2+-exchangers is located in the t-tubules 39. It has been shown that a 
fraction of the Na+/Ca2+-exchangers are localized as close to the RyR as the L-type 
Ca2+ channel 136 (but this is also disputed 109). This is compatible with a triggering role 
for reverse Na+/Ca2+-exchanger activity. The reversal of the Na+/Ca2+-exchanger
requires a combination of positive membrane potential and increased [Na+]ss. The 
reversal potential for the Na+/Ca2+-exchanger is typically -30 to -80 mV at rest 12.
Thus, during the action potential, the Na+/Ca2+-exchanger will reverse and cause 
Ca2+ influx. Several reports show that this Ca2+ entry can trigger SR Ca2+ release and 
contractions 5;148, even in the absence of ICa,L 72. During the initial phase of the action 
potential, Na+ will flow into the cell through Na+ channels. Thus, Na+ can accumulate 
in subsarcolemmal spaces adjacent to Na+/Ca2+-exchangers, facilitating Ca2+
influx 70;77. In a recent study it was shown that reverse mode Na+/Ca2+-exchange 
participates in early trigging of SR Ca2+ release, before trigging by ICa,L. It was 
predicted by a mathematical model that this was only possible if a Na+ channel was 
present in the dyad and if diffusion of Na+ in the dyad was slow 74. In a recent report it 
was concluded that INa might slightly enhance Ca2+ influx through Na+/Ca2+-
exchangers in the early phase of the action potential, consistent with a role for 
Na+/Ca2+-exchanger in early trigging 149. Further, other mechanisms regulating 
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[Na+]ss, such as the Na+/K+-ATPase, might be a determinant for the role of reverse 
mode Na+/Ca2+-exchange. Supporting this, it has been shown that the Na+/K+-
ATPase modulates the influence of INa on Ca2+ transients 129.
Despite all the current data, the physiological role of reverse mode Na+/Ca2+-
exchange as a trigger of SR Ca2+ release is still discussable. What seems clear, 
however, is that it might play an important role in heart failure. Indeed, several 
models of heart failure are associated with prolonged action potentials, increased 
[Na+]i and smaller Ca2+ transients, all of which will favour reverse mode Na+/Ca2+-
exchange activity 13. Also, increased expression of the Na+/Ca2+-exchanger in heart 
failure could influence trigging of SR Ca2+ release. 
3.2.3. Intracellular Ca2+ handling 
Trigger Ca2+ binds to RyRs, which then open and release a substantially larger 
amount of Ca2+ from the SR. The ensuing transient rise in [Ca2+]i allows binding of 
Ca2+ to troponin C in the myofilaments which causes actin and myosin filaments to 
interact and produce force. For relaxation to occur, the Ca2+ that came in over the 
sarcolemma as a trigger must be pumped back out of the cell, and Ca2+ released 
from the SR must be pumped back into the SR. These processes are summarized in 
Figure 3. 
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Figure 3. Ca2+ handling in cardiomyocytes. A section of the cardiomyocyte including the 
surface sarcolemma, a t-tubule and the sarcoplasmic reticulum (SR) is shown. The left 
panel shows how Ca2+ enters through L-type Ca2+ channels and reverse mode Na+/Ca2+-
exchangers, binds to ryanodine receptors (RyRs) and triggers a release of Ca2+ from the 
SR. The top panel shows how Ca2+ is extruded from the cell through forward mode 
Na+/Ca2+-exchanger and through the sarcolemmal Ca2+ ATPase. The right panel shows 
how Ca2+ is pumped back into the SR by SERCA. 
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Figure 4. The Ca2+ transient. 
Top panel: averaged Ca2+ transient 
from a confocal line scan image.  
Bottom panel: confocal line scan 
image from a field stimulated 
cardiomyocyte. Individual Ca2+ sparks 
can be observed as bright spots 
during diastole (arrows). 
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SR Ca2+ release 
L-type Ca2+ channels are present in the whole sarcolemma, but are more abundant in 
the t-tubules in proximity to RyRs located in the SR membrane 33;49. Indeed, the t-
tubule membrane is apposed to the SR membrane in highly specialized junctional 
microdomains. Here, L-type Ca2+ channels face RyRs with a stoichiometry of 4-10 
RyR for each L-type Ca2+ channel, depending on species 14. The two adjacent 
membranes are separated by a cleft of 10-15 nm which is called the dyadic cleft. 
Clusters of individual RyRs and L-type Ca2+ channels separated by a dyadic cleft 
constitutes a functional unit called a couplon, or dyad 18. The number of RyRs in one 
couplon is still a matter of debate; numbers from 6 to 40 are likely, although as many 
as 200 has been reported 12;64. When one or several L-type Ca2+ channels open 64,
Ca2+ release is triggered from the RyRs in that couplon by an amplification system 
(CICR). This can be observed as a Ca2+ spark in experiments 36;90 (see Figure 4). 
However, Ca2+ from one dyad does not normally diffuse to the next dyad. When an 
action potential travels through the cardiomyocyte, several individual Ca2+ sparks are 
triggered simultaneously and their spatiotemporal summation constitute the Ca2+
transient. Thus, it is the number of sparks recruited during an action potential (i.e. the 
number of open L-type Ca2+ channels) that determines the amplitude of the whole-
cell Ca2+ transient. However, the degree of amplification in CICR depends on the 
amount of Ca2+ stored in the SR: the SR Ca2+ load 115.
SR Ca2+ load 
The SR Ca2+ load at any given time point is determined by the balance between 
pumping of Ca2+ into the SR through a SR Ca2+ ATPase, SERCA, and Ca2+ efflux 
from the SR through RyRs. At steady-state, the amount of Ca2+ released through 
23 
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RyR during a transient equals the amount pumped back by SERCA. Likewise, trigger 
Ca2+ that flows into the cell over the sarcolemma is extruded through forward mode 
Na+/Ca2+-exchange (with a small contribution from a Ca2+ ATPase in the 
sarcolemma). Forward mode (Ca2+ extrusion) is the main exchange mode of the 
Na+/Ca2+-exchanger. It follows that SERCA and Na+/Ca2+-exchangers compete to 
remove cytosolic Ca2+. Therefore, when Na+/Ca2+-exchanger activity is altered, this 
will influence the SR Ca2+ load. At increased influx of Ca2+ over the sarcolemma, 
SERCA will pump more Ca2+ into the SR, leading to an increase in the SR Ca2+ load. 
This occurs within only one or two beats 115. The increased SR Ca2+ load sensitizes 
the RyRs towards Ca2+ triggers from the cytosolic side 55. The result is increased 
amplitude of the Ca2+ transient which will in turn lead to increased forward mode 
Na+/Ca2+-exchange and reduced Ca2+ influx through L-type Ca2+ channels due to 
increased Ca2+ dependent inactivation. Together, these mechanisms will normalize 
SR Ca2+ load 139. Thus, the SR Ca2+ load is continuously regulated by a negative 
feedback mechanism where the Na+/Ca2+-exchanger is an important determinant 142.
However, the most important regulator of SR Ca2+ load is SERCA, which will be 
discussed below. 
It is well established that the transport rate and exchange mode of the 
Na+/Ca2+-exchanger is controlled by intracellular concentrations of Na+ and Ca2+ as 
well as the membrane potential. Therefore, control of intracellular Na+ is essential for 
the cardiomyocyte in order to maintain normal contractility. A main regulator of [Na+]i
is the Na+/K+-ATPase. Therefore, the Na+/K+-ATPase can influence SR Ca2+ load. 
When [Na+]i increases, this will change the driving force of the Na+/Ca2+-exchanger, 
reducing Ca2+ extrusion through forward mode exchange. Blockade of the 
Na+/K+-ATPase by cardiac glycosides (digitalis, digoxin) will therefore increase the 
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SR Ca2+ load, and therefore also Ca2+ transients and contractions 12. However, at 
toxic levels cardiac glycosides will result in excessive amounts of Ca2+ in the SR 
(Ca2+ overload). Ca2+ overload of the SR will increase the opening probability of 
RyR 36, leading to an increased leak of Ca2+ through RyRs 116. This can cause 
spontaneous Ca2+ release and arrhythmias. Spontaneous openings of RyR in 
diastole, which also have been shown to occur during heart failure, will release Ca2+
which will be extruded through the Na+/Ca2+-exchanger. This extrusion causes a 
transient inward current (since the Na+/Ca2+-exchanger is electrogenic, transporting 
3 Na+ for 1 Ca2+), responsible for depolarizing the membrane towards the threshold 
for triggering of action potentials 98. This can cause delayed afterdepolarizations 
(DADs) 16. It follows that the Na+/Ca2+-exchanger has a dual role in the generation of 
DADs: 1, it controls the SR Ca2+ load, and 2, it carries the depolarizing current 142.
Thus, correct balance of the Na+/Ca2+-exchanger is important for maintaining cardiac 
function, particularly during heart failure when spontaneous openings of the RyR are 
likely to occur due to hyperphosphorylation 83 (see below). 
SR Ca2+ reuptake 
The amount of Ca2+ released from the SR is larger than the amount of Ca2+ entering 
over the sarcolemma. Therefore, at steady state, more Ca2+ has to be pumped back 
into the SR than out of the cell. Thus, despite the important role for the Na+/Ca2+-
exchanger in the regulation of SR load, the contribution of SERCA in removing Ca2+
from the cytosol is considerably greater than that of the Na+/Ca2+-exchanger. The 
relative contribution of SERCA vs. Na+/Ca2+-exchanger and sarcolemmal Ca2+
ATPase varies between species, and has been estimated to 70% in rabbits, and to 
92% in rodents 8. It follows that SERCA is the main determinant for the kinetics of 
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individual Ca2+ transients 142. SERCA is the centre of a macromolecular complex also 
containing regulatory proteins such as phospholamban, cAMP-dependent protein 
kinase A (PKA), Ca2+-calmodulin dependent protein kinase II (CaMKII) and protein 
phosphatases PP1 and PP2A. Its activity is determined by the [Ca2+]i  and the SR 
Ca2+ load and is regulated by phospholamban 43. An increase in [Ca2+]i will increase 
the activity of SERCA whereas increased SR Ca2+ load means that SERCA must 
pump against a steeper Ca2+ gradient, slowing the pumping rate 63. The Ca2+ affinity 
of SERCA is regulated by phospholamban, which can be phosphorylated by kinases 
and dephosphorylated by phosphatases. When dephosphorylated by PP1 or PP2A, 
phospholamban inhibits SERCA. Upon phosphorylation by PKA at Ser16 or CaMKII 
at Thr17, a conformational change in the protein structure relieves this inhibition. The 
consequence of a reduced SERCA activity is reduced SR Ca2+ load, resulting in a 
smaller Ca2+ transient. Due to this regulation by phosphorylation, SERCA activity is 
modulated by the ȕ-adrenergic system. A full ȕ-adrenergic effect can be mediated by 
PKA phosphorylation at Ser16. Phosphorylation at Thr17 by CaMKII may only occur 
after sufficient rise in [Ca2+]i and is additive to the effect of PKA phosphorylation 140.
Defects in intracellular Ca2+ handling during heart failure 
In heart failure, most studies report decreased SR Ca2+ load 60;73;96;97. There are at 
least three possible explanations for this: (1) Reduced SERCA function. This could 
be due to reduced amounts of SERCA protein, but such reduction is controversial 48.
More likely, reduced phosphorylation of phospholamban underlies decreased 
SERCA activity in heart failure 48;104. Reduced phosphorylation of phospholamban 
can partially be explained by the downregulation of ȕ-adrenergic receptors in heart 
failure, but also by increased activity of PP1 and PP2A 140. (2) Increased forward 
26 
Introduction
mode Na+/Ca2+-exchange. Several studies report 50-100% increased levels of 
Na+/Ca2+-exchanger mRNA, protein and current (INCX) 12. Higher forward mode 
Na+/Ca2+-exchange will compete better with SERCA during relaxation. This is 
supported by studies of ventricular cardiomyocytes with overexpressed levels of 
Na+/Ca2+-exchanger showing depressed contractility and reduced SR Ca2+ load 106
(3) Increased leak of Ca2+ from the RyR. It has been reported that RyR can be 
hyperphosphorylated by PKA in heart failure, increasing the open probability of RyR 
and thus reducing SR Ca2+ load 82;83. However, these results are controversial 17;152
and were recently contested in a study showing that increased Ca2+ leak through 
RyR was mediated through ȕ-adrenergic stimulation of CaMKII, independently of 
PKA or bulk [Ca2+]i 38. In heart failure, both the amount and activity of CaMKII are 
upregulated, resulting in enhanced RyR phosphorylation and diastolic SR Ca2+ leak 2.
The physiological importance of leaky RyRs is still unclear. The effect of increased 
RyR leak has been challenged by the demonstration that modulation of the systolic 
function of RyR only causes transient changes in SR Ca2+ release 45. It was recently 
also shown that increased RyR open probability could not produce SR Ca2+ leak 
unless SR Ca2+ content was increased 143. Thus, since leak actually reduces the 
SR Ca2+ load, leaky RyRs could help prevent SR Ca2+ overload 120. Nevertheless, 
leaky RyRs could participate in the genesis of triggered arrhythmias (DADs) as 
described above, especially if SR Ca2+ load is increased 143.
3.2.4. Role of intracellular Na+
The [Na+]i in cardiomyocytes is tightly regulated and results from the balance 
between Na+ influx mechanisms and Na+ efflux mechanisms. Na+ influx occurs 
through numerous mechanisms, primarily through Na+ channels and the Na+/Ca2+-
exchanger, but also through the Na+/H+-exchanger, co-transporters of Na+/HCO-3,
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Na+/K+/Cl- and Na/Cl-, and Na+/glucose and Na+/amino acid carriers 71. The main 
mechanism for Na+ efflux is the Na+/K+-ATPase, which is essential for keeping [Na+]i
low. The activity of the Na+/K+-ATPase can be adjusted to face an altered influx of 
Na+ over the sarcolemma. This occurs primarily by changing the affinity of the 
Na+/K+-ATPase for [Na+]i, but also by changing the maximal pump rate (Vmax) of the 
Na+/K+-ATPase. The principles for regulation of [Na+]i are presented in Figure 5 
where the transport rate of the Na+/K+-ATPase is plotted as a function of [Na+]i (dark 
blue line). At increasing Na+ influx (red arrow), the Na+/K+-ATPase will adjust its 
activity at a new higher [Na+]i. Increased intracellular Na+ affinity (K0.5) of the Na+/K+-
ATPase is represented by the leftward shifted dashed blue line. A study showed that 
in Na+ loaded cardiac Purkinje fibres, both Vmax and [Na+]i affinity were increased 
after addition of Ca2+ 114. This increased the Na+ efflux through the Na+/K+-ATPase.
These results show that recovery from high intracellular Ca2+ is closely linked to 
reduction of [Na+]i.
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Figure 5. Principles of regulation [Na+]i. For simplicity, Na+ influx is shown as a linear 
function of [Na+]i in a normal situation and during increased influx e.g. due to 
increased leak (higher influx). The Na+ transport rate by the Na+/K+-ATPase is shown 
as sigmoid saturation curves (Hill-curves) with a normal affinity for Na+ (full line) and 
increased affinity for Na+ (dotted line). Points of intersection reflect steady state [Na+]i.
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In recent years, evidence has accumulated for the existence of a 
subsarcolemmal space where [Na+]ss can vary largely from bulk [Na+]i 144. However 
very little is known about how the regulation of [Na+]ss occurs, and how [Na+]ss
influences Na+/Ca2+-exchanger activity. A possibility is that the subsarcolemmal 
space for Na+ may actually be small, separate “pockets” that are localized to various 
regions of the membrane. In this concept, localization of proteins is of crucial 
importance. Proteins located in separate “pockets” will not “see” the same [Na+]i, but 
they will if they are located within the same “pocket”. This might also underlie the 
existence of different isoforms of some proteins. For example, two isoforms are 
expressed for the Na+/K+-ATPase (see below). Thus, they might play different roles 
based on their localisation in a specific “pocket”. For example, a study of mice with 
genetically altered amounts of D1- and D2-isoforms suggest a selective involvement of 
the D2-isoform in Ca2+ regulation, whereas the D1-isoform plays a more 
“housekeeping” role 66. A recent study, similar to Paper 2 in this thesis, provided 
further evidence for such role for the D2-isoform 11.
 Increased [Na+]i is a common finding in models of heart failure. An increase of 
3 mM was recently found in a rabbit pressure and volume overload heart failure 
model 6;40. Increased [Na+]i will alter the driving force for the Na+/Ca2+-exchanger, 
favouring Ca2+ influx (trigger Ca2+) through reverse mode Na+/Ca2+-exchange. 
Increased reverse mode Na+/Ca2+-exchange was recently shown in a model of heart 
failure 93. Increased [Na+]i will also reduce Ca2+ efflux through forward mode during 
relaxation, thus contributing to the slow relaxation observed in heart failure. As a 
consequence, less Ca2+ will be transported out of the cardiomyocyte. This will tend to 
increase SR Ca2+ load, which might actually compensate for the reduced SR Ca2+
load commonly observed in heart failure. This could offset the depression of Ca2+
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transients and contractile function observed in heart failure 12. Clearly, it is important 
to examine how local [Na+] is regulated in the subsarcolemmal space, and how this 
regulates the Na+/Ca2+-exchanger.
3.3.The Na+/K+-ATPase
The Na+/K+-ATPase was first discovered in 1957 when J. C. Skou suggested that the 
transport of Na+ and K+ over the sarcolemma was coupled to a Na+ and K+ activated 
ATPase 125. 40 years later, the Nobel Prize in Chemistry was awarded for this 
discovery. An increasing number of studies have focussed on the role for the Na+/K+-
ATPase in the heart. However, few studies have assessed the functional role of 
different isoforms of the Na+/K+-ATPase. 
3.3.1. Structure and isoforms 
A functional Na+/K+-ATPase is assembled by at least one 110 kDa catalytic D-subunit
and one 35-55 kDa glycosylated ȕ-subunit. The D-subunit is composed of ~1000 
amino acid residues and spans the sarcolemma 10 times. It contains binding sites for 
Na+, K+, ATP and cardiac glycosides and phosphorylation sites 105. Thus, the function 
of the Na+/K+-ATPase depends mainly on the D-isoform present. Three different D-
isoforms, encoded by three distinct genes, have been identified in rat and human 
hearts, D1, D2, and D3 80;112;145. The D1-isoform is the predominant isoform whereas 
the D2 and D3 isoforms are expressed at lower levels 34. The D3-isoform is expressed 
in moderate amounts in neonatal rat ventricle, but this expression declines after birth 
whereas the expression of D2-isoform increases 34. The D3-isoform is barely 
detectable in protein homogenates from adult rat left ventricle 112.
30 
Introduction
The ȕ-subunit is a single span protein which contains ~300 amino acid 
residues 52. The C-terminus of the protein interacts with the D-subunit on the 
extracellular side 47. Three isoforms have been identified (ȕ1, ȕ2, ȕ3), but only ȕ1 and 
ȕ2 are found in heart tissue. However, the ȕ2-isoform is expressed at a very low level 
in both human 145 and rat hearts 118. A recent study suggested that in rats, ȕ1-
isoforms associate with D1- and D2-isoforms, whereas ȕ2-isoforms, although 
expressed at a very low level, associate with D3-isoforms in the intercalated discs 57.
The physiological role of the ȕ–subunit is still unclear, but it has been shown that it is 
indispensable for the assembly of the Na+/K+-ATPase 21;67, and that it regulates the 
level of Na+/K+-ATPase inserted in the cell membrane 84. A role for the ȕ-isoform in 
ATP hydrolysis, ion transport and binding of inhibitors such as ouabain has also 
recently been suggested 105.
During translocation of ions, the Na+/K+-ATPase cycle between two 
conformational states, E1 and E2. The ion binding site is accessible from only one 
side at any given time and a varying affinity for Na+ and K+ in each conformational 
state provide for which ion that binds to the ionophore. Thus, the Na+/K+-ATPase
translocates 3 Na+ out of the cell, and then 2 K+ into the cell using the metabolic 
energy of one ATP molecule. One net charge is moved out of the cell for each cycle, 
generating a small, but measurable current. The Na+/K+-ATPase pumps Na+ and K+
against their concentration gradients and is responsible for establishing and 
maintaining the electrochemical gradients for Na+ and K+ in cardiomyocytes. The 
density of Na+/K+-ATPase is several orders of magnitude higher than for Na+
channels (1200 vs. 3/μm2, 12), but the turnover rate is ~4 orders of magnitude slower 
(80-100/s, 52). However, the expression of the D-isoforms of the Na+/K+-ATPase is 
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heterogeneous in the sarcolemma. Despite several recent advances, a clear picture 
of this heterogeneous distribution has not yet been established. 
3.3.2. Regulation
The Na+/K+-ATPase is regulated at multiple levels. It is dependent on intracellular 
Na+, extracellular K+, ATP, and can be modulated by cardiac glycosides. Further, it 
has recently become evident that important modulation of Na+/K+-ATPase activity in 
cardiomyocytes occurs through regulation by phospholemman, a transmembrane 
protein.
Na+ and K+ dependence 
The Na+/K+-ATPase is regulated by its substrates: intracellular Na+ and extracellular 
K+. The half-maximal activation (K0.5) for Na+/K+-ATPase is reached at a [K+]o of 
~1.5 mM 89, so at a normal [K+]o of 4-5 mM, the Na+/K+-ATPase should be ~80% 
saturated with respect to [K+]o. This means that small variations in [K+]o have little 
effect on Na+/K+-ATPase activity. Binding of K+ to the Na+/K+-ATPase is considered 
voltage-dependent since K+ must pass an access channel within the electrical field 
across the sarcolemma to reach its binding site 52. Under experimental conditions, 
when K+ is low and at positive potentials, the rate of the Na+/K+-ATPase can be 
reduced by electrostatic inhibition of K+ binding 100. This can cause a negative slope 
of the current-voltage relationship of the Na+/K+-ATPase at positive potentials. 
 The K0.5 value for half-maximal Na+/K+-ATPase activation by [Na+]i has been 
difficult to establish due to varying experimental conditions in different studies. This 
variation can be ascribed to: 1, differences between species. 2, difficulties of 
clamping the [Na+]i by patch pipettes because of restricted diffusion in the 
subsarcolemmal space. 3, the fact that intracellular K+ are competitive inhibitors of 
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Na+ at intracellular Na+ binding sites, and [K+]i varies in different studies. However, at 
physiological conditions, the K0.5 for Na+ may be in the range of 10-20 mM 52;111;113
(but see also below about phospholemman). This is close to the normal resting [Na+]i
so small variations in [Na+]i can have dramatic effects on the Na+/K+-ATPase activity. 
The affinity of the Na+/K+-ATPase to intracellular Na+ increases during depolarization. 
This might play an important role during depolarization of the cardiomyocyte so that 
Na+/K+-ATPases pump out Na+ that came in through Na+ channels. Moreover, a low 
Na+/K+-ATPase activity during the resting potential might allow for accumulation of 
[Na+]i during the resting potential. Thus, the Na+/Ca2+-exchanger is allowed to 
reverse during the upstroke of the action potential, bringing Ca2+ into the cell to 
trigger Ca2+ release. 
Catalytic modulation 
The Na+/K+-ATPase hydrolyses a molecule of ATP for each cycle. Various K0.5
values for half-maximal Na+/K+-ATPase activation by ATP have been reported, 
ranging from 80 to 800 μM depending on species, isoforms and methods used 52;135.
However, physiological concentrations of ATP are in the order of 5-10 mM, and thus 
saturating for the activity of the Na+/K+-ATPase. Only under certain 
pathophysiological conditions, such as ischemia, a severe decrease in [ATP] in 
combination with an increase in [ADP], [Pi] and [H+] could reduce Na+/K+-ATPase
activity 110.
Cardiac glycosides 
Cardiac glycosides, such as ouabain and digitalis, are potent inhibitors of Na+/K+-
ATPase activity. They bind reversibly to the extracellular side of the D-isoform of the 
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Na+/K+-ATPase and inhibit ATP hydrolysis, and thus ion transport. The sensitivity of 
the Na+/K+-ATPase for ouabain varies largely depending on species and D-isoform.
In rats, mice and guinea pigs, the Na+/K+-ATPase current can be separated into a 
ouabain-sensitive and –insensitive component 65, although this separation is 
discussable in the guinea pig. These components correspond to the D2- and D1-
isoforms, respectively. The affinity for ouabain has been assessed in several species. 
Some results from intact ventricular cardiomyocytes are summarized in Table 1.
Table 1: Comparison of affinities for ouabain of Na+/K+-ATPase isoforms in different 
studies of intact ventricular cardiomyocytes 
Preparation Ouabain
affinity D1 K0.5
(μM) 
Ouabain
affinity D2 K0.5
(μM) 
[Na+]i
(mM) 
[K+]o
(mM) 
Re
f
Rat ventricular myocytes 141 0.38 100 4 41
Rat ventricular myocytes 43.4 19.9 10-3 50 5.4 133
Rat ventricular myocytes 43 1 15 or 100 15 65
Rat ventricular myocytes 33.9 1.1 15 or 100 15 10
Mouse ventricular myocytes 105 0.3 50 5 11
Guinea pig ventricular myocytes 72 (DHO) 0.75 (DHO) 50 or 10 1 or 4.6 50
Guinea pig ventricular myocytes 64.5 (DHO) 0.05 (DHO) 30 5.4 87
K0.5: concentration for half maximal activation, DHO: dihydroouabain 
As evident from the table, the affinity for ouabain of the Na+/K+-ATPase vary between 
studies, especially for the D2-isoform. An obvious explanation for this is the apparent 
difference between species, but it could also be due to different experimental 
conditions. In particular, it has been showed that association rate constants of 
ouabain on the Na+/K+-ATPase are dependent on [K+]o and [Na+]i 19. Extracellular K+
is antagonising the inhibition of INKA by ouabain, whereas augmented [Na+]i increases 
the probability for the Na+/K+-ATPase to take on a conformation that binds ouabain. 
However, the latter effect was most prominent between 5 and 15 mM of Na+ 52. Thus, 
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it seems important to determine the affinities for ouabain for each experimental 
condition used. 
 The inhibitory effect of the Na+/K+-ATPase by cardiac steroids is clinically 
relevant. Digitalis has been used in the treatment of heart failure, or “dropsy”, for 
more than 200 years 151. However, the mechanism of action is still not completely 
understood. The beneficial effect of Na+/K+-ATPase inhibition by digitalis is ascribed 
to the positive inotropic effect resulting from accumulation of cellular Ca2+. However, 
toxic effects are common, and might occur when cellular [Ca2+]i increase to excessive 
levels, causing arrhythmias and potentially sudden death. In a randomized controlled 
Digitalis Intervention Group (DIG) trial, no decrease in overall mortality was observed 
after treatment with digoxin, although hospitalizations were reduced in patients with 
an ejection fraction lower than 45% 134. However, a post hoc analysis of the DIG trial 
concluded that low serum concentrations of digoxin (0.5-0.9 ng/ml) reduced both 
mortality and hospitalizations in all heart failure patients 1. A possible explanation 
could be that at low doses, digoxin affects a subgroup of Na+/K+-ATPases giving a 
beneficial effect. At higher doses this beneficial effect could be blunted by the 
inhibition of other Na+/K+-ATPases responsible for toxic effects. However, this 
explanation remains speculative until experimental data becomes available. 
Phospholemman
In recent years, it has become evident that the Na+/K+-ATPase can be regulated by 
an associated, phosphorylable protein called phospholemman. Phospholemman is a 
small (72 amino acids) single span protein which belongs to a family of proteins 
called FXYD proteins, characterized by the presence of a conserved amino acid motif 
(Pro-Phe-X-Tyr-Asp). Phospholemman, which is also called FXYD-1, is mainly 
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expressed in the heart, skeletal muscle and liver 51. It has been shown by co-
transfection experiments in oocytes that phospholemman associates with Na+/K+-
ATPase D1- and D2-isoforms 37. However, in native membranes (bovine sarcolemma), 
the efficiency of co-immunoprecipitation with phospholemman was higher for the D1-
isoform than for the D2-isoform. Moreover, in a recent study with immunoprecipitation 
and immunofluorescence experiments, phospholemman was found associated with 
the D1-isoform, but not the D2-isoform 119. Binding of phospholemman to the Na+/K+-
ATPase caused a decrease in the apparent affinity for [Na+]i by nearly 2-fold, and 
also a small decrease in the affinity for [K+]o 37. This inhibitory role of phospholemman 
was further supported by using phospholemman knock-out mice 42. Here the authors 
demonstrated that inhibition of the Na+/K+-ATPase by phospholemman mainly occurs 
through reducing the affinity for [Na+]i. However, the inhibitory effect of 
phospholemman can be relieved through phosphorylation by both D- and ȕ-
adrenergic agonists. Phosphorylation of phospholemman occurs at two sites: Ser 63 
and Ser 68 in the C-terminal region. Ser 63 can be phosphorylated by PKC, and Ser 
68 can be phosphorylated by both PKC and PKA 13. Phosphorylation changes the 
interaction between phospholemman and the Na+/K+-ATPase, but does not lead to 
dissociation of the two proteins 13. However, the complete picture of how the 
regulation of Na+/K+-ATPase activity by phospholemman occurs is yet to be 
determined.
3.3.3. Alterations in Na+/K+-ATPase activity heart failure 
In various models of heart failure, decreased levels of Na+/K+-ATPase protein have 
been reported. In human heart failure there was an isoform specific decrease in the 
expression of D1ȕ1 and D3ȕ1 heterodimers in homogenates from left ventricle tissue. 
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The protein level of D2-isoforms was unaltered 108. Another study revealed a trend for 
overall decrease of Na+/K+-ATPase protein in human myocyte fractions (24%) 25,
although this reduction did not reach statistical significance. In rabbit heart failure, a 
36% overall decrease in Na+/K+-ATPase protein was observed using a pan-specific 
antibody 25, and expression of all isoforms was lower in myocytes (30%, 17%, and 
58% for D1, D2 and D3, respectively). In protein homogenates from a rat post infarction 
CHF model, expression of D1-isoforms was unaltered, whereas D2-isoforms were 
lowered by 55% and D3-isoforms were induced from a barely detectable level 112.
However, as pointed out in another study, the increase in D3-isoform is likely to occur 
in the non-myocyte fraction 25. The overall reduction in Na+/K+-ATPase protein could 
be an explanation for the increased [Na+]i observed during heart failure 40;95. A study 
concluded that the Na+/K+-ATPase pump capacity was reduced in CHF because of 
cardiomyocyte hypertrophy, so that a same number of pumps could not readily 
control [Na+]i 112. However, unaltered Na+/K+-ATPase capacity in heart failure has also 
been shown 40. Here, the authors suggested that the increase in [Na+]i was due to 
increased influx of Na+ through slowly inactivating Na+ channels. Another study 
explained the increased [Na+]i by an upregulation of the Na+/H+-exchanger 6. An 
explanation for reduced expression of Na+/K+-ATPase does not necessarily cause a 
decrease in Na+/K+-ATPase function came with the discovery that the expression of 
phospholemman is also reduced in heart failure 25. In combination with increased 
phosphorylation of phospholemman in heart failure, the inhibition of Na+/K+-ATPase
by phospholemman is blunted, resulting in unaltered Na+/K+-ATPase function 13.
Despite these recent data, alterations in Na+/K+-ATPase function during heart 
failure are not fully understood. Clearly, Na+/K+-ATPases as well as other proteins 
involved in excitation-contraction-relaxation cycle “see” the ion concentrations in their 
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immediate vicinity. These do not necessarily reflect the global ion concentration in 
the cytosol. Alterations in local “pockets” of ions could occur during heart failure, 
causing alterations in ion homeostasis. Such alterations could be due to remodelling 
of the cardiomyocyte structure, for example in the t-tubules. 
3.4.T-tubules in cardiomyocytes 
A particular feature of the sarcolemma in ventricular cardiomyocytes is the presence 
of transverse tubules (t-tubules). T-tubules are invaginations of the cell membrane 
which form a tortuous network in cardiomyocytes. Recent research has demonstrated 
that their structure and function plays an important role for cardiomyocyte function. 
3.4.1. Structure of the t-tubules 
T-tubules owe their name to early studies showing that they appear as transverse
segments at intervals of ~1.8 μm near the Z lines in cardiomyocytes 91. The Z lines 
are dark bands seen in the microscope which correspond to the protein structures 
between sarcomeres (Z is from the German zwischen which means between). Since 
then, it has become apparent that t-tubules also occur in the longitudinal direction 127.
A more recent study constructed a three-dimensional model of the t-tubules based on 
stacks of confocal images of live rat cardiomyocytes 126. The authors quantified the t-
tubules which occur near the Z line to ~60% of all the t-tubules, whereas the 
remaining ~40% occur between the Z lines. It has now become clear that the t-
tubules form a complex network containing branching tubules in both transverse and 
longitudinal directions 30.
 The diameter of the t-tubules varies from 20 to 450 nm, but more than 50% 
have a diameter of 180-280 nm 126. Their total volume has been estimated to 
0.8-3.6% of the cardiomyocyte volume (see 12 for Refs). Estimates of the fraction of 
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sarcolemma in the t-tubules (vs. surface membrane) range from 21-64% 12. However, 
experiments involving an osmotic shock (see 5.4 Detubulation) to uncouple the t-
tubules from the surface membrane show a ~30% decrease in cell capacitance upon 
detubulation 31. Although this large variability in the estimates of t-tubule morphology 
might reflect methodological aspects, it might also be due to the large plasticity of the 
t-tubules. Indeed, t-tubules are absent in the neonatal heart 35;56, and disappear when 
cells are kept in culture 76;78. Moreover, reports show remodelled t-tubule structures 
during heart failure (see below). How the t-tubules maintain their morphology, or fail 
to do so, is still uncertain. A working hypothesis could be that the t-tubules need a 
scaffold made of proteins in the cytoskeleton and that alterations in the cytoskeleton 
will cause t-tubule remodelling. Further studies are necessary to examine this 
possibility. 
3.4.2. Functional role of t-tubules 
By providing proximity between the sarcolemma, the SR and the contractile 
apparatus, the t-tubules predispose for an efficient coupling of electrical excitation of 
the cell membrane to Ca2+ release and contraction. Several studies have shown that 
the density of key proteins in excitation-contraction-relaxation coupling appears to be 
higher in the t-tubules than in the surface membrane 31: For example, L-type Ca2+
channel density is 6 times higher in the t-tubules than in the surface membrane 29. By 
this specialized subcellular localization, the L-type Ca2+ channels in the t-tubule 
membrane face RyR in the SR membrane in specialized microdomains (dyads) 
allowing efficient gain of the Ca2+ induced Ca2+ release. The importance of this 
coupling has been demonstrated in experiments with cardiomyocytes lacking t-
tubules (detubulated 28;153, cultured 78 and atrial 22). Here [Ca2+] initially rises near the 
surface membrane of the cell, and then diffuses into the cell interior, causing 
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dyssynchronous Ca2+ release. Thus, adequate subcellular localization of the L-type 
Ca2+ channel in the t-tubule membrane is necessary to allow synchronous Ca2+
release throughout the whole cardiomyocyte. 
Likewise, the densities of Na+/Ca2+-exchangers and Na+/K+-ATPases have 
been found 3 times higher in the t-tubules 39. Thus, co-localization of these proteins is 
likely, and they are possibly interacting to regulate [Na+]ss. However, how the t-
tubules contribute to a specialized microdomain for Na+ which is linked to Ca2+
handling is less well established. Moreover, alterations in t-tubule structure and 
function might disturb the co-localization of proteins and thus the microdomains for 
both Na+ and Ca2+, leading to mismanagement of Ca2+ handling. The results 
presented in this thesis shed new light into these issues. 
To summarize, the t-tubules allows an efficient, synchronous Ca2+ handling in 
the cardiomyocyte during the cardiac cycle without the need for individual ions to 
travel very far. This is important since diffusion of solutes appears to be slow in 
cardiomyocytes. In the same way, diffusion of ions could be slow in the t-tubules. 
Thus, the t-tubules might constitute a specialized compartment where ions can 
accumulate and deplete during the cardiac cycle. Such accumulations and depletions 
of ions may influence the spread of the action potential and proteins important in the 
excitation-contraction-relaxation coupling. 
3.4.3. Changes in t-tubules during heart failure 
Several recent reports show alterations in the t-tubular network in models of heart 
failure. He et al. 59 showed that the density of both transverse tubules and L-type 
Ca2+ channels was reduced in a canine model of tachycardia-induced heart failure. 
Other studies have demonstrated increased spatial dispersion of the t-tubules 
leading to Ca2+ instability in heart failure 32;79;128. However, the link between 
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alterations in the t-tubule structure and alterations in excitation-contraction-relaxation 
coupling is still missing 31. Whether it is the altered geometry of t-tubules in itself, or if 
it is the altered localisation of key proteins which plays the most important part in 
Ca2+ mismanagement is a matter of debate. It might be that altered geometry 
disrupts specialized microdomains, and that this in turn leads to alterations in ion 
handling proteins. 
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4. MAIN AIMS
Main aims: 
The main aims of the present thesis were to examine to which extent diffusion of ions 
is restricted in the t-tubules and in the intracellular compartment, and to investigate to 
which extent restricted diffusion of ions affects cardiac excitation-contraction 
coupling. 
Specific aims: 
Explore the role of the t-tubules as a separate functional compartment by examining 
whether diffusion of K+ is restricted in the t-tubules. 
Investigate the role of the Na+/K+-ATPase D2-isoform in the regulation of Na+/Ca2+-
exchanger activity. 
Determine the expression pattern of the Na+/K+-ATPase D2-isoform in heart failure 
and to identify the functional consequences of Na+/K+-ATPase D2-isoform
downregulation.
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5. METHODS
5.1.Animal model 
Hearts from male Wistar Hannover rats (Møllegaard Breeding and Research Center, 
Denmark) weighing ~300g were used in all animal experiments in this thesis. This is 
an outbred strain which has a larger biological variability than inbred strains. The 
choice of this animal model was based on ethical and economical considerations. 
Moreover, our laboratory has extensive experience with this strain. However, this 
strain also exhibits advantages for studying the problems addressed in this thesis. 
First; it has been reported that the rat has a more extensive t-tubule network than 
other species 30. With the reservation that this variation might be due to 
methodological rather than biological differences, it makes the rat a very suitable 
model for studying the questions addressed in Paper 1. Second; in contrast to other 
species, like humans 146, the various Na+/K+-ATPase isoforms in rat cardiomyocytes 
have different affinities for ouabain. This property was exploited in Papers 2 and 3. 
 However, some important differences between cardiomyocytes from rats and 
humans exist, restricting extrapolations of the results to humans 12;58: 1; the action 
potential of rat cardiomyocytes is much shorter and lacks a prominent plateau phase. 
2; the Na+/Ca2+-exchanger is relatively less important for Ca2+ removal from the 
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cytosol in rats than in humans. 3; the force frequency relationship is negative in rats, 
but positive in humans. 4; the resting rat heart rate is five times that of humans. 5; the 
levels of [Na+]i are higher in the rat. Despite these differences, the results presented 
in this thesis can increase our understanding of cardiomyocyte function. Further, the 
results can be compared with results obtained in rats in other laboratories around the 
world.
 In Paper 3, we have used a post infarction CHF model, mimicking human 
heart failure resulting from coronary artery occlusion. This model has been described 
in detail elsewhere 138. Also here, one should be careful to extrapolate our results to 
humans. Several differences exist between experimental heart failure in rats, and 
chronic heart failure in humans: 1; in the rats the coronary artery occlusion was 
induced in healthy young individuals, whereas myocardial infarctions in humans 
usually occur in the elder. 2; CHF in humans usually develops over years, whereas in 
our experimental model CHF was studied after 6 weeks. 3; CHF in humans is usually 
multifactorial 58.
5.2.Hemodynamics
Not all the animals with induced myocardial infarction developed CHF. As described 
by Sjaastad et al. 123, only rats with a left ventricular end diastolic pressure 
(LVEDP)  15 mmHg and increased lung weight were considered to have CHF. To 
verify that animals included in Paper 3 developed CHF, we catheterized the aorta to 
measure blood pressure and LVEDP using a 2F (0.67 mm) microtip pressure 
catheter (model SPR-407, Millar Instruments Inc., Houston, TX). This was also done 
in the Sham group for comparison. 
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5.3.Cell isolation 
Cell isolation is a crucial point in our experimental procedures. Bad cell quality is 
often associated with a low yield, cardiomyocyte instability and difficulties in obtaining 
a gigaohm seal (see 5.5 Electrophysiological methods). This often results in no, or at 
best poor quality recordings. Even though cell isolation procedures are so important, 
little space is left in published papers for this topic. Therefore, a short description of 
the procedure is presented, and important aspects are commented. 
 Isolated cardiac ventricular myocytes were prepared using an enzymatic 
perfusion method. After a thoracotomy, heparin was injected through vena cava 
inferior before excising the heart in order to avoid coagulation in the coronary 
arteries. The aorta of the excised heart was cannulated above the aortic valve and 
the coronary arteries were perfused with a preoxygenated solution at 37qC for 1-2 
minutes. An enzyme solution containing 1 g.l-1 collagenase type II (Worthington) was 
then perfused until the aortic valve was digested, as attested by the increased 
outflow of perfusate. We experienced that inadequate perfusion is one of the main 
reasons for obtaining a low yield of live cardiomyocytes at the end of the isolation 
procedure. This can probably be explained by poor oxygenation of the tissue and 
consequent cell death. Also, poor perfusion means that the enzyme is not delivered 
to all parts of the heart, leading to inefficient digestion of the tissue. Another critical 
factor for obtaining good quality cardiomyocytes is the collagenase. Several 
collagenases exist, but the type II from Worthington is recommended for digestion of 
heart tissue. However, a lot-to-lot variation is typical of such crude enzyme 
preparations, and makes it important to pre-test a particular lot of enzyme for 
experiments. The reason is that crude collagenase preparations contain not only 
collagenases but also a sulfhydryl protease, clostripain, a trypsin-like enzyme, and an 
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aminopeptidase. This combination of collagenolytic and proteolytic activities is 
effective at breaking down intercellular matrices, the essential part of tissue 
dissociation. It is the combined action of these enzymes that varies between lots. 
Empirically, we found that lots with a collagenase activity close to 200 U/ml gave a 
good yield.
 The cell isolation procedure potentially affects the cardiomyocytes studied in 
many ways. First, the collagenase could affect membrane proteins important to 
cardiomyocyte function, especially because of protease activity. Therefore, we did 
not switch between lots within comparable series of experiments. Second, to make 
sure that only cardiomyocytes from the left ventricle and septum were studied, the 
atria and the right ventricle were cut off early in the isolation procedure. Third, in 
hearts from CHF rats, a large part of the left ventricular free wall was infracted. The 
infarct area and border zone were cut off, leaving mainly the septum for experiments. 
Thus, our cell experiments in CHF are mostly representative of the septum. Fourth, 
regional differences exist within the left ventricle. However, in paired experiments, 
this would not cause a problem.
5.4.Detubulation
The detubulation technique of live cardiomyocytes using an osmotic shock was 
developed in Clive Orchards lab in 1999 68. Before this technique became available, 
t-tubules were studied mainly using immunohistochemical studies, telling tales of 
protein distribution, but not of protein function in the t-tubules. Detubulation has been 
used in several studies providing important information about t-tubule function in 
cardiomyocytes. However, some concerns can be raised concerning this technique. 
Formamide (HCONH2) which is used to induce the osmotic shock, is an amide 
analogous to urea (CO(NH2)2), and can potentially have direct effects on cardiac cells 
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due to its properties as a denaturant. Thus, disruption of protein-protein interactions 
as well as re-distribution of membrane proteins could occur. These problems were 
addressed in a paper by Brette et al. 28. The authors found that formamide treatment 
of atrial cells, which lack t-tubules, did not change cell capacitance, Ca2+ current 
amplitude, action potential configuration, the Ca2+ transient or the response of the 
Ca2+ transient to isoprenaline. Although these results did not prove the absence of 
possible protein re-distribution, they suggest that this is unlikely to occur. However, 
there is no direct proof in the literature today that Na+/K+-ATPases are not re-
distributed due to the formamide treatment. Therefore it is important to emphasize 
that in Papers 2 and 3, all conclusions as to the functional crosstalk with the 
Na+/Ca2+-exchanger and consequences for [Na+]i, contractions and Ca2+-transients
are independent of the detubulation experiments. Hence we did not interpret the 
detubulation experiments extensively, we only concluded as to whether the isoforms 
of the Na+/K+-ATPase were located in the surface membrane or in the t-tubules. 
5.5.Electrophysiological methods 
In all the studies in this thesis, we used a complex method generally known as the 
patch clamp technique to measure membrane potentials and currents across 
cardiomyocyte membranes. Although the term “patch clamp” originally refers to 
experiments studying individual ion channels in “patches” of cell membrane, it is also 
often referred to for whole-cell recordings, as in Papers 1-3. Patch clamping is a 
complicated technique, requiring many considerations. Here, only some of the 
principles will be presented, and implications for our experiments will be commented. 
For the patch clamp experiments, we used a glass pipette which constituted 
an electrode when filled with an electrolyte solution mimicking that of the cytosol. 
This electrode was pressed against the cell surface. When suction was applied in the 
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glass pipette, the cell membrane formed a tight seal with the electrode, a so-called 
“gigaohm” seal, since the electrical resistance of that seal is high. To access the 
whole cell, the membrane patch defined by the pipette tip was ruptured, establishing 
direct contact between the solution in the pipette and the cytosol. The mixing of these 
two solutions, also referred to as dialysis of the cell, depends on the size of the 
pipette tip. A bigger tip means lower electrical resistance of the electrode, and more 
efficient dialysis. This was a crucial point in Papers 2 and 3, where we “clamped” the 
intracellular solutions, in particular the [Na+]i.
 In all studies in this thesis, we used continuous single electrode voltage clamp 
(cSEVC). Here, a single electrode was used to clamp voltage and to pass current 
simultaneously. Since current flowing through a non-zero resistance (the electrode) 
necessarily produces a voltage drop across that electrode, this can introduce a 
source of error in the voltage clamping. The measured voltage is actually the sum of 
the voltage across the pipette and the membrane potential (which is what we want to 
measure). To keep the voltage drop to a minimum, the series resistance of the 
pipette can be compensated by the amplifier. However, due to practical limitations, 
100% compensation cannot be achieved. An alternative approach would be to use 
discontinuous single electrode voltage clamp (dSEVC). With that method, switching 
between passing of current and measuring of membrane potential would allow us to 
measure the true membrane potential, since almost no current is passed while 
measuring the membrane potential. Yet, dSEVC is also noisier, limiting its 
advantages in our experiments where currents are relatively small. Moreover, the 
advantages of dSEVC are particularly important in protocols where fast voltage steps 
are required. Measuring relatively slow changes in membrane potentials using 
cSEVC should not be a problem, since problems related to series resistance would 
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be negligible. The change in voltage in our experiments was several orders of 
magnitude slower than that allowed by the amplifier. For example, in Paper 1, the 
membrane potential changed with a maximum rate in the order of  ~0.02 mV/ms, and 
the junction potential in the order of ~0.2 mV/ms. This is several orders of magnitude 
slower than the rapid depolarisation of an action potential (in the order of ~200 
mV/ms). This was further confirmed by the similar kinetic parameters recorded both 
in voltage and current clamp in Paper 1. Also, the pipette resistance in our 
experiments was so low that errors due to series resistance were kept to a minimum. 
5.6.Contraction measurements 
In Paper 2 and 3, contractions were recorded in field stimulated cardiomyocytes 
using a video-edge detection system. Fractional shortening is typically reduced in 
post infarction CHF 121;123, but has also been reported to be unchanged 3;99. However, 
in Paper 3 we observed an increased fractional shortening of cardiomyocytes from 
CHF hearts. This discrepancy requires some considerations. 
First; in our experiments, cardiomyocytes were plated on laminin-coated 
coverslips, and were allowed to contract with little resistance against movement. This 
unloaded shortening is quite different from the in vivo situation where cardiomyocytes 
are connected to each other and therefore must contract against an afterload. Thus, 
results obtained using this method might not be representative for the in vivo
situation. Second; the cardiomyocytes were field stimulated by passing current in the 
cell bath. This is quite different from the in vivo situation where contractions are 
initiated by an action potential spreading form cell to cell. It has been reported that 
field stimulated cell contraction is independent of sodium currents, but is triggered by 
a combination of L-type Ca2+ current and reverse mode Na+/Ca2+-exchange 24. Third; 
our experiments were performed at 1 Hz. This is slow compared to physiologic heart 
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rates in rats. It was shown in human heart failure that reduced force of contraction 
was more apparent at physiological heart rates than at low frequencies 94. Moreover, 
because contractile properties can be similar in normal and failing muscles under 
basal conditions, but become apparent during stress, contractile dysfunction in CHF 
should be studies at variable rates of stimulation and during stimulation by inotropic 
drugs 61. However, in Paper 3 we studied the downregulation of the D2-isoform and 
consequences for regulation of contractility through the Na+/Ca2+-exchanger. Thus, a 
description of the altered contractile properties in CHF was beyond the scope of that 
paper.
5.7.Immunocytochemistry
In Paper 2 and 3 we used antibodies to study the subcellular distribution of Na+/K+-
ATPase D-isoforms. In this method, fixed, permeabilized cardiomyocytes are 
incubated with an antibody against the D1- and D2-isoforms of the Na+/K+-ATPase.
Then fluorochrome labelled secondary antibodies against the primary antibodies are 
used to visualize the localisation of the Na+/K+-ATPases. This permits signal 
amplification because several secondary antibodies binds to different antigenic sites 
on the primary antibody.
Several steps in the protocol are critical to obtain good quality immunostains. 
First of all, the specificity of the immunostain is dependent on the specificity of the 
antibody. Further, to reduce unwanted unspecific binding, the cells are incubated in 
goat serum to reduce the number of epitopes available for unspecific binding. The 
fixation and permeabilization conditions can also influence the integrity and 
availability of epitopes. Therefore optimizations of labelling protocols are required. 
This optimisation is often based on experience and empirical trial and failure. Thus, 
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to avoid variations in the images due to differences in labelling protocols, conditions 
were set equal in comparable series. Moreover, in experiments comparing Sham and 
CHF, labelling was performed in parallel the same day. 
During sampling of images on the confocal microscope, optical distortion 
occurs due to imperfections in the optical pathway. In our experiments, this “noise” 
was reduced by blind deconvolution using commercially available software 
algorithms (Huygens software, SVI, The Netherlands). This method deduces a point 
spread function, a mathematical function that describes the distortion which occurs 
during recording (convolution) of the image. Knowing this point spread function, the 
near original image can be computed. Deconvolution of images preserves 
quantitative relationships, and may therefore also be used in preparation for 
quantitative image analysis 131. Nevertheless, the optical resolution of confocal 
images still represents a limitation for determining close co-localization of molecules. 
Hence, this method is primarily useful for determining in which part of the cell the 
target protein is located (e.g. in our case the t-tubules vs. the surface membrane). 
5.8.Fluorescence
In Paper 1, 2 and 3 we have used fluorescent probes to visualize the sarcolemma, 
Ca2+ transients and intracellular Na+ concentrations. 
 The sarcolemma was visualized using di-8-ANEPPS (Invitrogen) which is a 
membrane binding molecule. It is less susceptible to internalization than other similar 
dyes, so labelling of intracellular membranes such as sarcoplasmic reticulum or 
mitochondria membranes is limited. 
 The rise and fall of the cytosolic Ca2+ level was visualized using fluo-4 
(Invitrogen). Upon excitation by light of a specific wavelength, fluo-4 exhibits a rapid 
increase in fluorescence intensity when binding to Ca2+. The fluo-4 was loaded into 
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the cells as an acetoxymethyl (AM) ester which can permeate cell membranes. In the 
cytosol, unspecific esterase activity cleaves off lipophilic blocking groups, leaving a 
charged form which leaks out of cells far more slowly than its parent compound. 
However, leak of dye into intracellular compartments could occur, influencing the 
recorded Ca2+ transient. In particular, leak into the mitochondria would cause a 
problem since they constitute ~35% of the cell volume 12. To avoid this, we loaded 
the cells at room temperature, which slows the speed of loading and leaves time for 
deesterification. The time of loading was also limited, although a minimum is required 
to get enough dye into the cell. Further, this loading protocol was standardized and 
used in comparable groups. An Argon laser was used to excite the fluorescent probe, 
representing high excitation intensity. To limit cell damage, the laser power and 
scanning time were reduced to a minimum. 
The intracellular Na+ concentration was measured using sodium-binding 
benzofurzan isophthalate (SBFI, Invitrogen). Traditionally, this dye is used in a dual 
excitation configuration, where the ratio of fluorescence intensities obtained by 
exciting at 340 nm and 380 nm, while measuring emission at 500 nm is used to 
determine the concentration of Na+. However, binding of SBFI to intracellular proteins 
cause a shift of excitation and emission spectra. This was assessed in a study by 
Baartscheer et al. 4. They demonstrated that SBFI used in dual emission mode 
provides a more sensitive and more specific method to measure small changes of 
[Na+]i in single cardiomyocytes. Thus, in Paper 2, SBFI was excited at 340 nm, and 
emission was collected at 410 nm and 590 nm. SBFI was loaded as an AM ester, 
and measures similar to those described for fluo-4 were taken to avoid leak of SBFI 
into intracellular compartments. Finally, the SBFI is a rather slow probe, and 
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therefore it was not possible to study transient changes in [Na+]i during the cardiac 
cycle.
5.9.Western blot analysis 
In Paper 2 and 3, we used Western blots to determine protein specificity and to 
measure protein levels in homogenates of left ventricle tissue. With this method, 
proteins are initially separated by sodium-dodecyl-sulphate (SDS)-polyacrylamide gel 
electrophoresis (PAGE) before they are blotted over to a membrane which is 
incubated with the primary antibody. The amount of antibody binding is determined 
by a secondary antibody labelled with horseradish peroxidase giving a luminescent 
product which can be detected using a light sensitive video camera. Western blot 
requires many methodological considerations. I will here only briefly point out some 
important points for the present thesis: 1, since the antibody-antigen affinity is 
specific to each antibody, the amount of protein loaded on the gel must be adjusted 
adequately for each antibody used. 2, the appearance of a single band indicates a 
high specificity of the antibody since the other proteins, which are present on the blot, 
are not labelled. 3, Western blot is a semi quantitative method, so it is not possible to 
calculate protein concentrations. However, the amount of protein can be compared in 
two groups, like we did in Paper 3. 4, due to large blot-to-blot variability, comparisons 
should always be made on the same blot. 5, considering the semi quantitative 
aspect, small changes in immunolabelling density should be interpreted with care. 
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6. RESULTS AND DISCUSSION
6.1.T -tubules constitute a functional compartment 
Despite the rather large diameter of t-tubules, the diffusion of solutes into the t-tubule 
appears to be slow 23;117;132;154. In Paper 1, we show that diffusion of K+ in the lumen 
of t-tubules is slow, ~85 μm2/s. For comparison, the diffusion of K+ in water is about 
nine fold faster 81. Thus, the t-tubules can act as compartments where K+ can 
accumulate and become depleted during the cardiac cycle. The experimental 
implication of our results is that during rapid perfusion of cardiomyocytes, a complete 
switch of the extracellular solution, including the lumen of the t-tubules, requires 
minimum 1 s. In the intact heart however, such rapid changes are unlikely to occur. 
Nevertheless, during the cardiac cycle, both influx and efflux of ions occur. A slow 
diffusion of K+ could lead to accumulation of K+ in the t-tubules during exercise. The 
role of extracellular K+ accumulation has been studied in skeletal muscle in which K+
shifts can cause muscle fatigue through the effect on muscle excitability and action
potentials 110. However, in the heart, the K+ balance appears to be much more
efficiently controlled 110. This is probably because the rise of [Na+]i, following for 
example an increase in heart rate, is sufficient to activate the Na+/K+-ATPase to 
completely compensate increased K+ release. However, in heart failure where the 
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Na+/K+-ATPase capacity could be reduced, as shown in Paper 3, and also by another 
study 112, the slow diffusion of K+ could have greater consequences. Increasing heart 
rate when the capacity of the Na+/K+-ATPase is reduced could lead to increased 
[K+]o. The membrane will depolarize by almost 18 mV for each doubling of [K+]o 110.
Thus, the resting membrane potential is brought closer to threshold for triggering an 
action potential. However, as seen in skeletal muscle, the effects of changes in [K+]o
on electrical properties are complex, and there is not a simple linear relationship 
between [K+]o and force development 110. Thus, even if hyperkalemia is a common 
cause of cardiac arrhythmias 92, two factors cause hyperkalemia to actually reduce 
cardiomyocyte excitability: (1) An increased [K+]o increases the conductance of IK1.
Increased conductance of IK1 means that more inward Na+ current is required to 
trigger an action potential. (2) The depolarized membrane potential increases the 
fraction of inactivated Na+ channels 12. Due to the complexity of this regulation, a 
rough and ready calculation on the effect of stimulation rate on membrane potential 
based on our diffusion data would be speculative.
 As discussed in Paper 1, the causes for the restricted diffusion are uncertain, 
but probably results from the tortuous structure of the t-tubules and because of ion 
binding sites in the t-tubule membrane and glycocalyx. In Paper 3, we observed 
altered structure of the t-tubule network structure during heart failure. Although we 
did not determine whether ion binding sites were altered, there was a transition in the 
morphology of t-tubules. In particular, there was a lesser association between the SR 
membrane and the t-tubule membrane. We speculate that such spatial alterations 
could lead to disturbances in local microdomains on both sides of the t-tubule 
membrane. This could constitute a structural basis for alterations observed in heart 
failure. Functional changes commonly observed in heart failure can be mimicked in 
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experiments with detubulated cells. These changes include reduced and slowed Ca2+
transient, less synchronized SR Ca2+ release, decreased response of ICa,L to ȕ-
adrenergic stimulation, and decreased contractile response to cardiac glycosides 31.
Thus, intact t-tubule function is of crucial importance for cardiac function. 
6.2.Na+/K+-ATPase D2-isoform is preferentially located in t-
tubules
The function of t-tubules in providing proximity between proteins involved in 
excitation-contraction-relaxation coupling is illustrated by the fact that precise 
targeting of L-type Ca2+ channels so that they face RyRs in the couplon is 
indispensable for synchronous Ca2+ release 79;128. In Paper 2 and 3, we observed 
that the D2-isoform of the Na+/K+-ATPase was preferentially located in the t-tubules of 
cardiomyocytes whereas the D1-isoform was more abundant in the surface 
sarcolemma. However, controversy exists. By immunohistochemistry, studies have 
shown uniform distribution of D1- and D2-isoforms in the surface membrane with little 
staining in the t-tubules (rat) 130, uniform distribution of D2-isoform in the whole 
sarcolemma, but D1-isoform mainly in t-tubules (rat) 85, D1-isoforms predominantly in 
surface sarcolemma and D2-isoforms mainly in the t-tubules (guinea-pig) 119.
However, in these studies, different antibodies were used and the discrepancies in 
these results probably reflect differences in antibody specificity. Further, different 
accessibility of epitopes might exist between the t-tubules and the surface 
sarcolemma. This stresses the need to confirm data by functional measurements. In 
Paper 2 and 3, we confirmed our immunocytochemistry data on the functional level 
by comparing currents recorded in control and detubulated cardiomyocytes. Our 
results were similar to those obtained recently by Berry et al. in mice 11. They 
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concluded that the D1-isoform was almost uniformly distributed between t-tubules and 
surface sarcolemma whereas the D2-isoform was ~5 times more concentrated in the 
t-tubules. Further, it has previously been shown that the density of Na+/Ca2+-
exchangers is higher in the t-tubules than in the surface sarcolemma 39;136. Thus, 
colocalization of Na+/Ca2+-exchanger with D2-isoforms seems likely, and a Na+/Ca2+-
exchanger regulatory role for Na+/K+-ATPase D2-isoform can be predicted. 
6.3.Na+/K+-ATPase D2-isoform regulates cardiac function 
A main finding in Paper 2 and 3 is that the D2-isoform normally constitutes only a 
small fraction (8-11%) of all the Na+/K+-ATPases in the cardiomyocyte. This is in line 
with other reports 11;75. Yet, a substantial contractile effect was observed when the 
D2-isoform was inhibited by a low dose of ouabain (0.3 μM). A positive inotropic effect 
resulting from inhibition of the Na+/K+-ATPase has been ascribed to an increase in 
intracellular [Na+]i, resulting in increased Ca2+ influx via the Na+/Ca2+-exchanger 7. In 
Paper 2, we showed that both diastolic and systolic [Ca2+]i increased during blockade 
of the D2-isoform, but we did not detect any increase in bulk [Na+]i with SBFI. 
However, with the method used, we could not isolate [Na+] in the subsarcolemmal 
space from bulk [Na+]. Thus, a possible explanation is that [Na+]i increased only in 
the subsarcolemmal space. By snap-freezing cardiomyocytes and measuring the 
total [Na+] in samples of small volumes at different sites in the cell, Wendt-
Gallitelli et al. demonstrated that [Na+] can be substantially higher in spaces beneath 
the membrane than in the bulk cytosol 150. Since the activity of the Na+/Ca2+-
exchanger is controlled by [Na+]i, we measured INCX to assess subsarcolemmal [Na+].
Abrupt activation of INKA led to a decrease in INCX, presumably due to local depletion 
of [Na+]i in the vicinity of the Na+/Ca2+-exchanger. This decrease was smaller when 
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the D2-isoform was inhibited by a low dose of ouabain, indicating that the D2-isoform
is necessary to modulate [Na+]i close to the Na+/Ca2+-exchanger. Thus, the Na+/K+-
ATPase D2-isoform and the Na+/Ca2+-exchanger may be tightly coupled in local 
microdomains in the t-tubules of cardiomyocytes. Alterations in colocalization or 
protein levels within this microdomain might have profound consequences for cardiac 
function.
6.4.Downregulation of Na+/K+-ATPase D2-isoform in heart 
failure impairs cardiac function 
In a previous study from our laboratory, it was shown that the D2-isoform was 
downregulated whereas the D1-isoform remained unchanged in CHF 112. It was also 
shown that D3-isoform expression increased from a barely detectable level. However, 
these experiments were performed on homogenates from cardiac tissue, and it was 
not possible to separate cardiomyocytes from other cell types in the heart. More 
recently, it was shown in a rabbit aorta banding heart failure model that, although the 
D3-isoform was increased in homogenates, it was actually reduced in isolated 
cardiomyocytes, suggesting that the increased expression of D3-isoform occurs in 
non-myocytes 25. In that study, the D2-isoform was reduced in both homogenates and 
isolated cells. However, the functional consequences of a reduction in D2-isoform
have not been assessed. In Paper 3 we studied the consequences of downregulation 
of the D2-isoform. 
First, it was crucial to determine whether the D2-isoform was functionally 
reduced in CHF. The inhibitory effect of the low dose of ouabain on INKA at a holding 
potential of -50 mV was reduced by 78% in CHF, suggesting that the D2-isoform was 
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functionally reduced. This was in surprisingly good agreement with the protein levels 
measured by immunoblots in protein homogenates (74%). Further, cardiomyocyte 
contractions were measured at 1 Hz in field stimulated cardiomyocytes. Here, 
baseline contractions (fractional shortening) were actually larger in CHF than in 
Sham. This is in agreement with some studies showing that at low stimulation rates, 
the contractile defect in heart failure can be blunted 103. An explanation for this was 
given in a recent study, where it was reported that increased baseline [Na+]i was 
responsible for maintaining contractility at low heart rates in a feline model of 
hypertrophy (by increasing the SR Ca2+ load) 86. In our study, we did not measure 
[Na+]ss directly in intact cardiomyocytes. However, in dialyzed cells, when INKA was 
abruptly activated after a [Na+]i loading period, INCX decreased in Sham, presumably 
because of local depletion of [Na+]ss. This decrease was smaller when the D2-isoform
was downregulated (CHF) or inhibited (low dose ouabain), indicating depletion of 
[Na+]ss to a lesser extent in these cells. Thus, downregulation of the D2-isoform could 
increase the [Na+]ss in baseline conditions, and constitute a compensatory 
mechanism to counteract reduced SR Ca2+ load at low heart rates. Further studies 
are necessary to determine the effects of downregulated D2-isoforms at higher heart 
rates.
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7. MAIN CONCLUSION
The present thesis demonstrates that diffusion of ions is restricted in the t-tubules 
and in the subsarcolemmal space. A functional consequence is that ions can 
accumulate and become depleted in local pools without affecting bulk ion 
concentrations. Thus, precise targeting of proteins involved in the excitation-
contraction-relaxation coupling to discrete regions of the sarcolemma is important for 
the regulation of cardiac function. 
The conclusions for each specific aim are: 
Conclusion 1 
The diffusion rate for K+ in t-tubules of rat cardiomyocytes is slow, ~85 μm2/s. This 
means that K+ ions, and probably other ions, can accumulate or deplete in discrete 
locations in the t-tubules during the cardiac cycle. This could play an important role 
for cardiomyocyte function by influencing the spread of the action potential, and by 
influencing membrane proteins involved in excitation-contraction-relaxation coupling. 
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Conclusion 2 
The Na+/K+-ATPase D2-isoform constitutes only ~11% of all the Na+/K+-ATPases in 
rat cardiomyocytes. However, by localisation in discrete locations in the t-tubules of 
rat cardiomyocytes, the D2-isoform is efficiently coupled to the Na+/Ca2+-exchanger. 
This occurs through a subsarcolemmal local pool of Na+, and constitutes an 
important regulatory mechanism of cardiomyocyte contractility. 
Conclusion 3 
Altered t-tubule network structure and downregulation of the D2-isoform in a rat post 
infarction CHF model cause attenuated control of Na+/Ca2+-exchanger activity, 
presumably due to local alterations in [Na+]i. This indicates that the Na+/K+-ATPase
D2-isoform is necessary to modulate [Na+]i close to the Na+/Ca2+-exchanger.
Downregulation of Na+/K+-ATPase D2-isoform might constitute a molecular basis for 
altered contractile properties in CHF. 
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8. ERRATA
Paper 2 
Paragraph 3.2., page 112, lines 8-10: The sentence should read: "...was compared to 
the mean fluorescence intensity of 30 distinct regions of the t-tubules." 
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